Introduction {#sec1-1}
============

*Comamonas testosteroni* is an aerobic Gram-negative bacillus that is oxidase positive, motile, nonspore forming, nonglucose fermenting, and arranged either singly or in pairs.\[[@ref1]\] It was formerly known as *Pseudomonas testosteroni*, and now this bacillus was reclassified by molecular genetics. It was renamed as *C. testosteroni* as it is known to use testosterone as the sole source of carbon for their growth. Although it has low virulence potency, however, there are few case reports on its involvement in human infections. became clinically important after 1987 when reports began accumulating on human infections such as peritonitis, cellulitis, endocarditis, meningitis, pneumonia, endophthalmitis, and tenosynovitis\[[@ref2]\] but cases of bloodstream infections caused by *C. testosteroni* have been infrequently reported. *C. testosteroni* is commonly found in soil, water saprophytes, and plants. It has also been detected in the water of in-use hospital oxygen humidifier reservoirs, hemodialysis solutions, urine, mucus, prostate tissue, stool, and respiratory secretions of cystic fibrosis patients.\[[@ref3]\] However, it has not been recognized as a component of the endogenous human microflora. The genus *Comamonas* originally contained following species: *Comamonas terrigena, C. testosteroni, Comamonas denitrificans Comamonas nitrativorans*, and *Comamonas kerstersii*. It now contains 17 species, while *Comamonas acidovorans* has been separated from the genus on the basis of its 16S rRNA gene and is now known as *Delftia acidovorans*. Although pathogenic potential of *C. testosteroni* has not been studied well, it is usually considered as a commensals. Around 36 cases have been reported in medical literature concerning *C. testosteroni* infection so far.\[[@ref3]\] Herewith, we are reporting the first documented case of *C. testosteroni* bloodstream infection from India.

Case Report {#sec1-2}
===========

A 46-year-old female from rural area admitted to our hospital with chief complains of high-grade fever (103°F), headache, fast breathing, and burning micturition for the past 6 days. On examination, other findings were such as respiratory rate 82/min, bilateral fine crepitation, pulse rate 146/min, and blood pressure 140/90 mmHg. Central nervous system, cardiovascular system, and per abdominal examinations were within normal limit. Other relevant laboratory findings include hemoglobin 10 gm%, total white blood cell count 24,200/cmm, neutrophil 90%, lymphocyte 10%, fasting blood sugar -- 88 mg/dl, erythrocyte sedimentation rate 50 mm after 1 h, Na -- 123 m. mol/L, K -- 4.2 m. mol/L, blood urea -- 45 mg/dl, serum creatinine -- 1.8 mg/dl, urine routine microscopy shows pus cells 6--10/hpf, albumin-trace, and no parasites. Serological tests such as HBsAg, HIV, HCV, and dengue (NS1Ag, IgM, and IgG) were negative by Enzyme-linked immunosorbent assay. Chest X-ray shows bilateral opacities in lower lobe and ultrasound sonography (USG) abdomen was normal. Blood was collected with complete aseptic precaution in aerobic and anaerobic blood culture bottle (BacT/ALERT/3D; bioMerieux, Marcy l\'Etoile, France). The patient was then started empirically with piperacillin + tazobactam and vancomycin. Aerobic blood culture bottle showed a positive sign of growth after 72 h. The broth was then subcultured on 5% sheep blood agar and MacConkey agar. After overnight incubation, MacConkey agar showed nonlactose fermenting colony but colony morphology was better seen after 48 h of aerobic incubation. Colonies were 1--2 mm in diameter, translucent, smooth surface, and nonpigmented \[[Figure 1](#F1){ref-type="fig"}\]. Blood agar plate showed similar colony morphology and nonpigmented. Gram-stain was done from both the culture plates, and it was Gram-negative bacilli. It was motile by hanging drop method. Routine biochemical tests were done and it was catalase positive, oxidase positive, indole not produced, urea not hydrolyzed, citrate not utilized, TSI medium showed both slant, and butt alkaline without H~2~S production. There was no hemolysis on blood agar culture plate. Further identification was done by VITEK-2 (fully automated identification system) using GN-25 card (bioMerieux, Marcy l\'Etoile France). It was identified as *C. testosteroni* with 98% probability. There was no growth in anaerobic blood culture bottle even after 7 days of anaerobic incubation. Urine sample was also sent to the microbiology department for culture and sensitivity. It was processed on Cysteine lactose electrolyte deficient media and similar colony morphology was seen as on MacConkey and blood agar. Further identification was done by VITEK-2 using GN-25 card, and again it was identified as *C. testosteroni* with 97% probability. The isolation of same bacteria from both the clinical samples (blood and urine) confirmed its pathogenic role. The isolate was found to be sensitive to gentamicin, amikacin, imipenem, meropenem, ciprofloxacin, tigecycline, cotrimoxazole, cefuroxime, colistin, and resistant to piperacilline-tazobactam. Therapy was changed to gentamicin 4 mg/kg/dose daily and imipenem 25 mg/kg/dose 8 hourly for 10 days. The patient responded well to antibiotic therapy. Fever was subsided 3^rd^ day after starting therapy. Blood sample was taken again for culture, 7 days after completion of antibiotic therapy, and it was negative. Urine sample was also collected with complete aseptic precaution for culture and there was no growth. The patient is doing well during follow-up.

![Nonlactose fermenting colony of *Comamonas testosteroni* on MacConkey agar](JLP-11-87-g001){#F1}

Discussion {#sec1-3}
==========

*C. testosteroni* is a widely distributed aerobic Gram-negative bacillus which is rarely seen as a human pathogen. Now a day, this bacterium has been identified in various hospital devices; however, it has not been recognized as a component of the endogenous human microflora. Because this bacterium has been more frequently encountered (till now around 36 cases), we thought that this case would be beneficial for clinicians and laboratory physicians in their diagnosis and clinical approach\[[@ref4]\] \[[Table 1](#T1){ref-type="table"}\]. Majority of the infections are community-acquired rather than nosocomial.\[[@ref5][@ref6]\] Most of the previously reported patients were immunodeficient due to malignancy, chronic liver disease, and end-stage renal disease taking hemodialysis.\[[@ref7][@ref8]\] However, in our case, the patient was immunocompetent based on the results of their previous reports. *C. testosteroni* is the most common species among its various species causing human infection and majority of the patients were survived. Till now around 16 cases of *C. testosteroni* bacteremia reported in medical literature, and out of which majority were male but our case was a female patient. Most of the patient responded well to appropriate antimicrobial therapy. *Comamonas species* are usually susceptible to aminoglycosides, fluoroquinolones, carbapenems, piperacillin-tazobactam, trimethoprim-sulfamethoxazole, and cephalosporins.

###### 

*Comamonas testosteroni* infections in the medical literature

  Age/sex           Diagnosis                                                           Sample                    Antibiotic treatment                  Result       References
  ----------------- ------------------------------------------------------------------- ------------------------- ------------------------------------- ------------ ------------------------
  54 years/female   Catheter related infection                                          Blood                     Cefepime, ciprofloxacin               Recovered    Abraham *et al*.
  50 years/male     Cholesteatoma                                                       CSF                       Meropenem                             Recovered    Arda *et al*.
  31 years/female   Bacteremia                                                          Bone marrow               Kanamycin, tetracycline               Recovered    Atkinson *et al*.
  31 years/male     Appendicitis                                                        Abscess                   Cefoxitin                             Recovered    Barbaro *et al*.
  24 years/female   IVDA                                                                CSF                       Moxalactam and nafcillin              Recovered    Barbaro *et al*.
  59 year/female    Alcoholic cirrhosis                                                 Peritoneal fluid          Cefoxitin                             Recovered    Barbaro *et al*.
  11 years/male     Appendicitis                                                        Peritoneal fluid          Ampicillin, clindamycin, tobramycin   Recovered    Barbaro *et al*.
  12 years/female   Appendicitis                                                        Peritoneal fluid          Cefoxitin                             Recovered    Barbaro *et al*.
  21 years/female   Appendicitis                                                        Peritoneal fluid          Cefoxitin                             Recovered    Barbaro *et al*.
  NB/Stillbirth     Maternal IVDA                                                       Umblical cord-blood       \-                                    Stillbirth   Barbaro *et al*.
  84 years/female   CHF                                                                 Urine                     Ampicillin                            Recovered    Barbaro *et al*.
  24 years/male     Appendicitis                                                        Peritoneal fluid          Cefoxitin                             Recovered    Barbaro *et al*.
  Female/NB         Maternal IVDA                                                       Blood                     Ampicillin, amikacin                  Dead         Barbaro *et al*.
  49 years/male     Infective endocarditis                                              Blood and mitral valve    Cefepime, gentamicin                  Recovered    Cooper *et al*.
  No data           AIDS                                                                Respiratory secretions    Ceftazidime                           Recovered    Franzetti *et al*.
  22 years/male     Appendicitis                                                        Peritoneal fluid, blood   Cefazolin                             Recovered    Gul M *et al*.
  75 years/female   Catheter related infection                                          Blood and CVC             Ceftazidime, gentamicin               Recovered    Le Moal *et al*.
  54 years/male     Cellulitis                                                          Blood                     Oxacillin, ciprofloxacin              Recovered    Tsui *et al*.
  73 years/male     Intra-abdominal infection and hepatocellular carcinoma              Blood                     Gentamicin, levofloxacin              Recovered    Tsui *et al*.
  82 years/female   Endophthalmitis                                                     Vitreous biopsy           \-                                    Recovered    Reddy *et al*.
  83 years/male     Bacteremia                                                          Blood                     Amikacin, piperacillin-tazobactam     Recovered    Katircioglu *et al*.
  63 years/female   Catheter related bloodstream infection in patient on hemodialysis   Blood                     Vancomycin, ceftriaxone               Dead         Nseir *et al*.
  10 years/male     Bacteremia                                                          Blood                     Ciprofloxacin, amikacin               Recovered    Farshad *et al*.
  19 years/female   Bacteremia                                                          Blood                     Ciprofloxacin, vancomycin, imipenem   Recovered    Farshad *et al*.
  51 years/male     Endocarditis                                                        Aortic valve              Ciprofloxacin                         Recovered    Arzu Duran *et al*.
  80 years/female   Bacteremia                                                          Blood                     Cefazolin and doripenem               Recovered    Orsini Jose *et al*.
  42 years/female   Septic shock                                                        Blood and urine           Ceftazidime and levofloxacin          Recovered    Hyun Jung Kim *et al*.
  65 years/female   Gastroenteritis                                                     Stool                     Ciprofloxacin and probiotics          Recovered    Shaika Farooq *et al*.
  46 years/female   Bacteremia                                                          Blood and urine           Gentamicin and imipenem               Recovered    Present case

CVC=Central venous catheter, CSF=Cerebrospinal fluid, CHF=Congestive heart failure, AIDS=Acquired immune deficiency syndrome, IVDA=Intravenous drug abuse, NB=Newborn

Until 1987, *C. testosteroni* has only rarely been associated to human infections. In the late 1980s, researchers reported 18 unrelated cases during a research \>3 years suggesting that this species might be missed if not carefully identified by clinical microbiology laboratories. Although the pathogenic potential of *C. testosteroni* has not been well studied, it is usually considered a commensal. Because *C. testosteroni* can be isolated from fresh water, it seems likely that wound infection could occur after contact with contaminated water.

Intra-abdominal infections are the most common infections caused by *C. testosteroni*. Bacterial translocation from gastrointestinal tract seems to play an important role in the pathogenesis caused by *Comamonas* species.\[[@ref9]\] The high genetic pliability of *Comamonas* species, as well as their inherent ability as an environmental pathogen to survive in various ecological niches, makes it an appropriate candidate to cause mild but persistent infections, particularly in an individual with predisposing conditions. In our case, there was no obvious source of infection. The patient did not have central venous catheters, USG abdomen did not show any mass. The patient did not have any immunological deficiency such as malignancy and diabetes mellitus. HIV status was negative. All these factors might have played a role as predisposing factors. In the present case, the patient belongs to rural area so the source of infection might be the contaminated food and water, although this hypothesis cannot be proven. It is only presumed as there was no proven source of infection.

Polymicrobial bacteremia involving *C. testosteroni* have been reported in association with *Streptococcus parasanguis, Streptococcus agalactiae, Ralstonia pickettii*, and *Bacteroides fragilis*.\[[@ref10]\] *C. testosteroni* is able to survive in the hospital environment for a long time, and majority of infections are community acquired. It is anticipated that nosocomial infection related to this bacterium will increase over time as there is increase in long hospital stay with impaired immune system and long-term use of the intravenous catheter. Most of the laboratories are not well equipped to detect such atypical pathogens that can cause human infection in certain clinical settings. Therefore, automated identification system (VITEK-2) can help to identify such rare isolates. In this case report, we have highlighted an unusual cause of bloodstream infection caused by *C. testosteroni*. *Comamonas* species should be kept in mind as a rare cause of bacteremia. The main target to report such an unusual case is to sensitize clinicians and clinical microbiologists for bloodstream infections caused by such unusual pathogens. However, more research should be done to understand the pathogenicity, virulence mechanism, and increased antibiotic resistance of *C. testosteroni*.
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